Gibson Energy Confirms 2025 Second Quarter Earnings Release Date and Provides Conference Call & Webcast Details

Gibson Energy Confirms 2025 Second Quarter Earnings Release Date and Provides Conference Call & Webcast Details GlobeNewswire July 10, 2025 CALGARY, Alberta, July 10, 2025 (GLOBE NEWSWIRE) — Gibson Energy Inc. (TSX:GEI) (“Gibson” or the “Company”) announced today that it expects to release its 2025 second quarter financial and operating results on Monday, July 28, […]

Frequency Electronics, Inc. Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results

(NasdaqGM:FEIM), MITCHEL FIELD, N.Y., July 10, 2025 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is reporting revenues for the three and twelve months ended April 30, 2025, of approximately $20.0 million and $69.8 million, respectively, compared to revenues of $15.6 million and $55.3 million, for the same period of fiscal year

Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

(NASDAQ:COGT), WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its previously announced upsized underwritten public offering of 25,555,556 shares of its common stock, which includes 3,333,333 shares issued pursuant to

United Fire Group, Inc. announces senior notes offering

(NASDAQ:UFCS), CEDAR RAPIDS, Iowa, July 10, 2025 (GLOBE NEWSWIRE) — United Fire Group, Inc. (UFG) (Nasdaq: UFCS), a property and casualty insurance holding company, today announced that it has successfully completed a placement of $30 million aggregate principal senior unsecured 9.0% Series B notes due May 31, 2039, (the “notes”) in a private offering (the

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy

(NasdaqGM:IOVA), SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the appointment of Marc. R Theoret, M.D. to assume the newly created position of Senior Vice President,

Caro Holdings Introduces Full-Cycle AI Automation Framework to Solve Execution Gaps for Small Businesses

(OtherOTC:CAHO),(OTC US:CAHO), SHEFFIELD, United Kingdom, July 10, 2025 (GLOBE NEWSWIRE) — Caro Holdings Inc. (OTC:CAHO), through its subsidiary, announced the launch of a full-cycle AI automation framework to help small and mid-sized businesses implement systems that deliver measurable outcomes – without the complexity or cost of enterprise platforms. The launch addresses frustration among SMEs, where

Frequency Electronics, Inc. Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results

Frequency Electronics, Inc. Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results GlobeNewswire July 10, 2025 MITCHEL FIELD, N.Y., July 10, 2025 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is reporting revenues for the three and twelve months ended April 30, 2025, of approximately $20.0 million and $69.8 million, respectively,

Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire July 10, 2025 WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases,

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy GlobeNewswire July 10, 2025 SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the

Caro Holdings Introduces Full-Cycle AI Automation Framework to Solve Execution Gaps for Small Businesses

Caro Holdings Introduces Full-Cycle AI Automation Framework to Solve Execution Gaps for Small Businesses GlobeNewswire July 10, 2025 SHEFFIELD, United Kingdom, July 10, 2025 (GLOBE NEWSWIRE) — Caro Holdings Inc. (OTC:CAHO), through its subsidiary, announced the launch of a full-cycle AI automation framework to help small and mid-sized businesses implement systems that deliver measurable outcomes

Scroll to Top